You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p53 Peptide

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

Not yet recruiting
  • Relapsing-remitting Multiple Sclerosis
  • CT-P53
  • +2 more
  • (no location specified)
Jun 7, 2023

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

    Completed
    • Endometrial Cancer
    • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
    • Alexandria, Egypt
      Hossam Hassan El Sokkary
    Sep 13, 2022

    Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Zanubrutinib plus RCHOP
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 16, 2023

    Infiltrating Duct Carcinoma of the Breast

    Not yet recruiting
    • Invasive Breast Cancer
      • (no location specified)
      Jan 28, 2023

      Dental Caries Trial in Cairo (Peptide)

      Completed
      • Dental Caries
      • Cairo, Egypt
        Faculty of Dentistary - Al-Azhar University
      Jan 4, 2023

      Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

      Not yet recruiting
      • Endometrial Cancer
      • Vaginal brachytherapy
      • +2 more
      • (no location specified)
      Nov 29, 2022

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

      Recruiting
      • Multiple Myeloma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 12, 2023

      Unusual Infiltrative Patterns of Malignant Cells in Endometrial

      Not yet recruiting
      • Endometrial Cancer
        • (no location specified)
        Mar 11, 2023

        Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

        Not yet recruiting
        • Age-related Wet Macular Degeneration
        • CG-P5 peptide
        • +2 more
        • Augusta, Georgia
        • +3 more
        Nov 13, 2023

        White Spot Lesion Trial in Alexandria (Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR, Fluoride

        Completed
        • White Spot Lesion
        • Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR
        • Fluoride varnish (DURAFLOR
        • Alexandria, Egypt
          Alexandria Faculty of Dentistry
        Feb 1, 2023

        Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

        Active, not recruiting
        • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
        • Plasma Cell Myeloma
        • Incomplete Freund's Adjuvant
        • +4 more
        • Buffalo, New York
        • +1 more
        Dec 12, 2022

        Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

        Not yet recruiting
        • Glioma, Malignant
        • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
        • Hiltonol
        • Durham, North Carolina
          The Preston Robert Tisch Brain Tumor Center at Duke University
        Jan 19, 2023

        Secondary Obliteration of Old Radical Cavities Using S53P4

        Recruiting
        • Mastoid Cavity
        • S53P4 bioactive glass granules
        • Utrecht, Netherlands
          Diakonessenhuis
        Nov 1, 2023

        Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

        Not yet recruiting
        • Endometrial Cancer
        • (no location specified)
        Aug 4, 2022

        Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

        Recruiting
        • Systemic Amyloidosis
        • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
        • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
        • Knoxville, Tennessee
          University of Tennessee Graduate School of Medicine
        Jul 10, 2023

        Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)

        Recruiting
        • Locally Advanced Cervical Cancer
        • Curcumin
        • Curcumin + Piperine
        • Mexico City, Mexico
          Instituto Nacional de Cancerología
        Oct 6, 2023

        DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

        Not yet recruiting
        • DLBCL
        • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
        • Qingdao, Shandong, China
          the affiliated hospital of Qingdao University
        Aug 18, 2022

        Vulvar Cancer Trial in Vancouver (Re-excision)

        Not yet recruiting
        • Vulvar Cancer
        • Re-excision
        • Vancouver, British Columbia, Canada
          BC Cancer - Vancouver Centre
        Oct 8, 2022

        Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

        Completed
        • Advanced Cancers
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jul 8, 2022

        Systemic Amyloidosis Trial in Knoxville (Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01))

        Active, not recruiting
        • Systemic Amyloidosis
        • Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)
        • Knoxville, Tennessee
          University of Tennessee Graduate School of Medicine
        Jul 28, 2023

        DLBCL Trial (Sintilimab, Rituximab)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • (no location specified)
        Mar 6, 2022

        Endometrial Cancer Trial in Vancouver (Treatment de-escalation)

        Recruiting
        • Endometrial Cancer
        • Treatment de-escalation
        • Vancouver, British Columbia, Canada
          BC Cancer - Vancouver Centre
        Mar 1, 2022